Proposed FDA user fee acts : Generic Drug User Fee amendments of 2012 (GDUFA) and Biosimilar User Fee Act of 2012 (BSUFA).

Proposed FDA user fee acts : Generic Drug User Fee amendments of 2012 (GDUFA) and Biosimilar User Fee Act of 2012 (BSUFA).

Saved in:

Bibliographic Details
Format:	Electronic eBook
Language:	English
Published:	[Washington, District of Columbia] : Congressional Research Service, [2012]
Series:	CRS report for Congress ; R42540. U.S. Congressional documents.
Subjects:	United States. > Generic Drug User Fee Amendments of 2012. United States. > Food and Drug Administration > Rules and practice. Generic drugs > Law and legislation > United States. Drugs > Prices > Law and legislation > United States. User charges > Law and legislation > United States. Legislative materials.
Online Access:	CONNECT

Similar Items

Generic drug user fee amendments (GDUFA) : background and reauthorization /
by: Bodie, Agata
Published: (2021)

Generic drugs and GDUFA reauthorization : in brief.
Published: (2016)

Generic drugs and GDUFA reauthorization : in brief.
Published: (2017)

Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
Published: (2008)

Examining FDA's prescription drug user fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
Published: (2018)

Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
Published: (2018)

Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 9, 2013.
Published: (2013)

Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 9, 2013.
Published: (2013)

Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.
Published: (2018)

Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.
Published: (2018)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining generic drug user fee amendments, focusing on accelerating patient access to generic drugs, January 28, 2016.
Published: (2018)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.
Published: (2018)

The Prescription Drug User Fee Act : structure and reauthorization issues /
by: Vogt, Donna U., et al.
Published: (2002)

Expanding the use of generic drugs.
Published: (2010)

Generic drug laws : a decade of trial -- a prescription for progress /
Published: (1986)

Animal drug user fee programs.
Published: (2018)

Animal drug user fee programs /
by: Lister, Sarah A.
Published: (2008)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)

FDA user fees and the regulation of drugs, biologics, and devices : comparative analysis of S. 3187 and H.R. 5651.
Published: (2012)

FDA medical product user fee reauthorization : in brief.
Published: (2017)

Authorized generics : an interim report.
Published: (2009)

An Act to Amend the Federal Food, Drug, and Cosmetic Act to Reauthorize User Fee Programs Relating to New Animal Drugs and Generic New Animal Drugs.
Published: (2018)

An Act to Amend the Federal Food, Drug, and Cosmetic Act to Reauthorize User Fee Programs Relating to New Animal Drugs and Generic New Animal Drugs.
Published: (2018)

An Act to Amend the Federal Food, Drug, and Cosmetic Act to Reauthorize User Fee Programs Relating to New Animal Drugs and Generic New Animal Drugs.
Published: (2013)

The FDA medical device user fee program : MDUFA IV reauthorization /
by: Johnson, Judith A. 1957-
Published: (2016)

Generics and biosimilars initiative journal : GaBI journal.
Published: (2012)

Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (to accompany H.R. 2375) (including cost estimate of the Congressional Budget Office).
Published: (2020)

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007.
Published: (2008)

Implementing user fees in the Food and Drug Administration : a case study.
Published: (1990)

Generic drugs : the pay-for-delay problem /
Published: (2011)

Amending the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs : report (to accompany H.R. 1407) (including cost estimate of the Congressional Budget Office).
Published: (2013)

Drug wars : how big pharma raises prices and keeps generics off the market /
by: Feldman, Robin
Published: (2017)

The FDA medical device user fee program /
by: Johnson, Judith A. 1957-
Published: (2012)

Generic drug entry prior to patent expiration : an FTC study.
Published: (2002)

Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Animal drug user fee agreements : advancing animal health for the public : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, first session on examining animal drug user fee agreements, focusing on advancing animal health for the public health, February 27, 2013.
Published: (2014)

FDA human medical product user fee programs /
by: Bodie, Agata, et al.
Published: (2021)

Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
Published: (2013)

Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
Published: (2013)

The FDA medical device user fee program : MDUFA IV reauthorization.
Published: (2017)